{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:37Z","timestamp":1793686357315,"version":"4.5.1"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFHZ0205"],"award-info":[{"award-number":["2024YFHZ0205"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270690"],"award-info":[{"award-number":["32270690"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118065","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:20:34Z","timestamp":1755498034000},"page":"118065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Immunomodulatory effects of anti-diabetic therapies: Cytokine and chemokine modulation by metformin, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists (2013\u20132025)"],"prefix":"10.1016","volume":"299","author":[{"given":"Amin","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2899-1531","authenticated-orcid":false,"given":"Bairong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118065_bib1","series-title":"Diabetes, (StatPearls","author":"Sapra","year":"2023"},{"key":"10.1016\/j.ejmech.2025.118065_bib2","first-page":"520","article-title":"Chronic complications of diabetes and quality of life","volume":"61","author":"Kolari\u0107","year":"2022","journal-title":"Acta Clin. Croat."},{"key":"10.1016\/j.ejmech.2025.118065_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118065_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2337\/dc17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.118065_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"Association","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.118065_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2 diabetes and diabetic complications","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.ejmech.2025.118065_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ejmech.2025.118065_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s10020-024-00905-9","article-title":"Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications","volume":"30","author":"Chen","year":"2024","journal-title":"Mol Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/dc20-1964","article-title":"Metformin benefits: another example for alternative energy substrate mechanism?","volume":"44","author":"Giaccari","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.118065_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/BJ20150497","article-title":"Repurposing metformin: an old drug with new tricks in its binding pockets","volume":"471","author":"Pryor","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2025.118065_bib12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2025.118065_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2025.118065_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jcpt.13225","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45","author":"Trujillo","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ejmech.2025.118065_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1462965","article-title":"Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis","volume":"15","author":"Yuan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib16","first-page":"548","article-title":"SGLT-2i\u2014A useful tool for real-life metabolic and body weight control in type 2 diabetes mellitus patients","volume":"61","author":"Popoviciu","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib17","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/dc22-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in Diabetes\u20142022","volume":"45","author":"Committee","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.118065_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111730","article-title":"CXCL13 and CXCR5 are upregulated in PCOS mice ovaries but downregulated following metformin administration","volume":"556","author":"Ullah","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11154-023-09800-w","article-title":"A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: type 2 diabetes and nonalcoholic fatty liver disease","volume":"4","author":"Ullah","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2023.1272536","article-title":"Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus","volume":"11","author":"Ullah","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.118065_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122277","article-title":"Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer : prognosis and therapeutic molecules","volume":"336","author":"Ullah","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11154-024-09884-y","article-title":"Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)","volume":"25","author":"Ullah","year":"2024","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s11658-024-00591-9","article-title":"The role of proinflammatory cytokines and CXC chemokines (CXCL1\u2013CXCL16) in the progression of prostate cancer: insights on their therapeutic management","volume":"29","author":"Ullah","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejmech.2025.118065_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107213","article-title":"Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: insights from preclinical and clinical studies' outcomes","volume":"204","author":"Ullah","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.ejmech.2025.118065_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor-alpha: Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2025.118065_bib27","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","article-title":"Targeting inflammation in the treatment of type 2 diabetes: time to start","volume":"13","author":"Donath","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.118065_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1055087","article-title":"The role of inflammation in immune system of diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications","volume":"13","author":"Yue","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.118065_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/nu12020382","article-title":"Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: data from an in vivo model","volume":"12","author":"Cassano","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2025.118065_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/01913123.2020.1762815","article-title":"Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats","volume":"44","author":"Dawood","year":"2020","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.ejmech.2025.118065_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910822","article-title":"Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists","volume":"22","author":"Winiarska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib32","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1002\/jcp.27427","article-title":"Interleukin-18 and diabetic nephropathy: a review","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.118065_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41419-021-04184-8","article-title":"AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice","volume":"12","author":"chun Han","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118065_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4093\/dmj.2015.39.6.451","article-title":"Autophagy: a novel therapeutic target for diabetic nephropathy","volume":"39","author":"Kume","year":"2015","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ejmech.2025.118065_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120578","article-title":"Effect of aerobic exercise as a treatment on type 2 diabetes mellitus with depression-like behavior zebrafish","volume":"300","author":"Wang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib36","doi-asserted-by":"crossref","first-page":"E835","DOI":"10.1152\/ajpendo.00145.2020","article-title":"Worsening baroreflex sensitivity on progression to type 2 diabetes: localized vs. systemic inflammation and role of antidiabetic therapy","volume":"319","author":"Bakkar","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2025.118065_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3255401","article-title":"Fufang fanshiliu decoction revealed the antidiabetic effect through modulating inflammatory response and gut microbiota composition","volume":"2022","author":"Li","year":"2022","journal-title":"Evidence-Based Complement Altern Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.25122\/jml-2020-0029","article-title":"The influence of metformin to the transcriptional activity of the mTOR and FOX3 genes in parapancreatic adipose tissue of streptozotocin-induced diabetic rats","volume":"2020","author":"Putilin","year":"2020","journal-title":"J Med Life"},{"key":"10.1016\/j.ejmech.2025.118065_bib40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/molecules27031027","article-title":"Nanoparticles of Costus speciosus ameliorate diabetes-induced structural changes in rat prostate through mediating the pro-inflammatory cytokines IL 6, IL1\u03b2 and TNF-\u03b1","volume":"27","author":"Bakhshwin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118065_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopha.2016.07.023","article-title":"Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats","volume":"83","author":"Garc\u00eda-D\u00edaz","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/antiox13091029","article-title":"Phytochemical profile and antidiabetic, antioxidant, and anti-inflammatory activities of Gypsophila paniculata ethanol extract in rat streptozotocin-induced diabetes mellitus","volume":"13","author":"Usatiuc","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.118065_bib43","article-title":"Tetrahedral framework nucleic acid (tFNA)-Loaded metformin (Met) modulates cellular pyroptosis and AMPK to ameliorate type II diabetic periodontitis","author":"Han","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.ejmech.2025.118065_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2024.101014","article-title":"Antidiabetic and antioxidant properties of Boswellia sacra oleo-gum in streptozotocin-induced diabetic rats","volume":"15","author":"Al-Matubsi","year":"2024","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib45","article-title":"Annatto-extracted tocotrienols improve glucose homeostasis and bone properties in high-fat diet-induced type 2 diabetic mice by decreasing the inflammatory response","volume":"8","author":"Shen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib46","article-title":"Modulation of altered immune parameters IL-2 and TNF-\u03b1 in diabetic animal models: a therapeutic insinuation of metformin beyond diabetes","volume":"2","author":"Ali","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2025.118065_bib47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fendo.2019.00939","article-title":"Combination of oligofructose and metformin alters the gut microbiota and improves metabolic profiles, contributing to the potentiated therapeutic effects on diet-induced Obese animals","volume":"10","author":"Li","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119116","article-title":"Bambusa vulgaris leaf extract inhibits the inflammatory and oxidative pathways in streptozotocin-induced diabetic rats","volume":"339","author":"Aladenika","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib49","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.3390\/molecules28155870","article-title":"Research progress of takeda G protein-coupled receptor 5 in metabolic syndrome","volume":"28","author":"Gou","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118065_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1027212","article-title":"Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1186\/s12967-024-05922-0","article-title":"Conjugated bile acids alleviate acute pancreatitis through inhibition of TGR5 and NLRP3 mediated inflammation","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111744","article-title":"Bone effects of metformin monotherapy and its combination with teneligliptin: a 12-week follow-up study in patients with type 2 diabetes mellitus","volume":"213","author":"Shaik","year":"2024","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2025.118065_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7608964","article-title":"Pathophysiology and management of type 2 diabetes mellitus bone fragility","volume":"2020","author":"Eller-Vainicher","year":"2020","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116774","article-title":"Antioxidative and anti-diabetic effects of Tapinanthus cordifolius leaf extract on high-fat diet and streptozotocin-induced type 2 diabetic rats","volume":"176","author":"Chike-Ekwughe","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40200-022-01090-4","article-title":"Evaluation of curcumin effect on Il6, Sirt1, TNF\u03b1 and NFkB expression of liver tissues in diabetic mice with STZ","volume":"22","author":"Mojtabavi","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402452","article-title":"Sandwich-structured nanofiber dressings containing MgB2 and metformin hydrochloride with ROS scavenging and antibacterial properties for wound healing in diabetic infections","author":"Fang","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ejmech.2025.118065_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6796470","article-title":"Empagliflozin-metformin combination has antioxidative and anti-inflammatory properties that correlate with vascular protection in adults with type 1 diabetes","volume":"2022","author":"Jani\u0107","year":"2022","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.25122\/jml-2023-0301","article-title":"Empagliflozin alone and in combination with metformin mitigates diabetes-associated renal complications","volume":"17","author":"Madhag","year":"2024","journal-title":"J Med Life"},{"key":"10.1016\/j.ejmech.2025.118065_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1153653","article-title":"Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in Obese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled trial","volume":"14","author":"El-Khateeb","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib60","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2147\/DDDT.S208327","article-title":"Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study","volume":"13","author":"Mo","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejmech.2025.118065_bib61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00125-018-4748-2","article-title":"Non-traditional biomarkers and incident diabetes in the diabetes prevention program: comparative effects of lifestyle and metformin interventions","volume":"62","author":"Goldberg","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2025.118065_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.15586\/aei.v52i4.1101","article-title":"Effect of metformin on gut microbiota imbalance in patients with T2DM, and the value of probiotic supplementation","volume":"52","author":"Li","year":"2024","journal-title":"Allergol. Immunopathol."},{"key":"10.1016\/j.ejmech.2025.118065_bib63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00109-024-02465-1","article-title":"Metformin improves cognitive dysfunction through SIRT1\/NLRP3 pathway\u2013mediated neuroinflammation in db\/db mice","volume":"102","author":"Hu","year":"2024","journal-title":"J Mol Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib64","article-title":"Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo","volume":"13","author":"Han","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118065_bib65","article-title":"Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium","volume":"17","author":"Li","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118065_bib66","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.2147\/DDDT.S307257","article-title":"Metformin in combination with malvidin prevents progression of non-alcoholic fatty liver disease via improving lipid and glucose metabolisms, and inhibiting inflammation in type 2 diabetes rats","volume":"15","author":"Zou","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejmech.2025.118065_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231187493","article-title":"Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation","volume":"14","author":"Shi","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.ejmech.2025.118065_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105566","article-title":"Portulaca oleracea L. (purslane) improves the anti-inflammatory, antioxidant and autophagic actions of metformin in the hippocampus of diabetic demented rats","volume":"168","author":"Hassan","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.118065_bib69","first-page":"2335","article-title":"Metformin and bee venom: a comparative detection of histological alteration of the pancreas and systemic inflammatory markers in diabetic mice","volume":"77","author":"Al-Sarray","year":"2022","journal-title":"Arch Razi Inst"},{"key":"10.1016\/j.ejmech.2025.118065_bib70","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v68.10749","article-title":"Brazil nut (Bertholletia excelsa) and metformin abrogate cardiac complication in fructose\/STZ-induced type 2 diabetic rats by attenuating oxidative stress and modulating the MAPK-mTOR\/NFkB\/IL-10 signaling pathways","volume":"68","author":"Li","year":"2024","journal-title":"Food Nutr. Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib71","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3390\/molecules26113441","article-title":"Malaysian propolis and metformin synergistically mitigate kidney oxidative stress and inflammation in streptozotocin-induced diabetic rats","volume":"26","author":"Nna","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118065_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.52547\/rbmb.10.1.30","article-title":"Efficacy of photobiomodulation and metformin on diabetic cell line of human periodontal ligament stem cells through Keap1\/Nrf2\/Ho-1 pathway","volume":"10","author":"Abdelgawad","year":"2021","journal-title":"Reports Biochem Mol Biol"},{"key":"10.1016\/j.ejmech.2025.118065_bib73","article-title":"Metformin prevents diabetes development in type 1 diabetes models via suppression of mTOR and STAT3 signaling in immune cells","volume":"15","author":"Suzuki","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib74","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41598-020-60213-0","article-title":"Metformin-induced suppression of IFN-\u03b1 via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes","volume":"10","author":"Saenwongsa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114080","article-title":"The combination of exercise and metformin inhibits TGF-\u03b21\/Smad pathway to attenuate myocardial fibrosis in db\/db mice by reducing NF-\u03baB\u2013mediated inflammatory response","volume":"157","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.31083\/j.rcm2505173","article-title":"Endurance exercise prevented diabetic cardiomyopathy through the inhibition of fibrosis and hypertrophy in rats","volume":"25","author":"Shabab","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2022.03.010","article-title":"Co-administration of hydrogen and metformin exerts cardioprotective effects by inhibiting pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"183","author":"Zou","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib78","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14494","article-title":"Cardiac hypertrophy and fibrosis were attenuated by olive leaf extract treatment in a rat model of diabetes","volume":"46","author":"Asghari","year":"2022","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.ejmech.2025.118065_bib79","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/ijms24010585","article-title":"Metformin attenuates hyperglycaemia-stimulated pro-fibrotic gene expression in adventitial fibroblasts via inhibition of discoidin domain receptor 2","volume":"24","author":"Titus","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib80","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/ijms25042424","article-title":"TGF-\u03b21 signaling impairs metformin action on glycemic control","volume":"25","author":"Pan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114530","article-title":"Metformin-mediated protection against immunosenescence in diabetic cardiomyopathy: the potential roles of GDF-15 and klotho proteins","volume":"153","author":"Almohaimeed","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib82","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/s41598-021-81349-7","article-title":"Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib83","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdi.14404","article-title":"The effect of exercise on GDF-15 levels in individuals with prediabetes: a randomized controlled trial","volume":"16","author":"Y\u0131ld\u0131r\u0131m Ayaz","year":"2025","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ejmech.2025.118065_bib84","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cbf.3289","article-title":"Effect of metformin and celecoxib on cytotoxicity and release of GDF-15 from human mesenchymal stem cells in high glucose condition","volume":"35","author":"Zafarvahedian","year":"2017","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ejmech.2025.118065_bib85","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.3390\/ijms22179393","article-title":"Metformin attenuates postinfarction myocardial fibrosis and inflammation in mice","volume":"22","author":"Loi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108737","article-title":"Metformin improves diabetic neuropathy by reducing inflammation through up-regulating the expression of miR-146a and suppressing oxidative stress","volume":"38","author":"Liu","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ejmech.2025.118065_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115893","article-title":"Beneficial effects of metformin supplementation in hypothalamic paraventricular nucleus and arcuate nucleus of type 2 diabetic rats","volume":"437","author":"Yu","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106893","article-title":"Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats","volume":"104","author":"Mohamed","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejmech.2025.118065_bib89","article-title":"Effects of metformin on renal function, cardiac function, and inflammatory response in diabetic nephropathy and its protective mechanism","volume":"2022","author":"Zhang","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ejmech.2025.118065_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40200-020-00541-0","article-title":"Metformin\/donepezil combination modulates brain antioxidant status and hippocampal endoplasmic reticulum stress in type 2 diabetic rats","volume":"19","author":"Obafemi","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23427","article-title":"Diabetic cardiomyopathy in rats was attenuated by endurance exercise through the inhibition of inflammation and apoptosis","volume":"10","author":"Shabab","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118065_bib92","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s40200-020-00637-7","article-title":"Concurrent metformin and silibinin therapy in diabetes: assessments in zebrafish (Danio rerio) animal model","volume":"19","author":"Mohammadi","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib93","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cancers12071857","article-title":"Metformin and probiotics in the crosstalk between colitis-associated colorectal cancer and diabetes in mice","volume":"12","author":"Al Kattar","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2025.118065_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.944323","article-title":"Linagliptin in combination with metformin ameliorates diabetic osteoporosis through modulating BMP-2 and sclerostin in the high-fat diet fed C57BL\/6 mice","volume":"13","author":"Nirwan","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib95","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.2147\/IJN.S506631","article-title":"Optimized nanostructured lipid carriers for metformin: enhanced anti-inflammatory activity and protection against type 2 diabetes-induced organ damage","volume":"20","author":"Qushawy","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ejmech.2025.118065_bib96","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.dsx.2020.08.016","article-title":"Effect of metformin and insulin combination on monocyte chemoattractant protein-1 and cathepsin-D in type 2 diabetes mellitus","volume":"14","author":"Kher","year":"2020","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.ejmech.2025.118065_bib97","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cbin.11184","article-title":"Hyperglycemia induces NF-\u03baB activation and MCP-1 expression via downregulating GLP-1R expression in rat mesangial cells: inhibition by metformin","volume":"43","author":"Kang","year":"2019","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejmech.2025.118065_bib98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-016-0344-2","article-title":"Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction","volume":"15","author":"Bakhashab","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81427-6","article-title":"Metformin-loaded nanoparticles reduce hyperglycemia-associated oxidative stress and induce eNOS phosphorylation in vascular endothelial cells","volume":"14","author":"Mohamed","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/ijms19010293","article-title":"Proangiogenic effect of metformin in endothelial cells is via upregulation of VEGFR1\/2 and their signaling under hyperglycemia-hypoxia","volume":"19","author":"Bakhashab","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib101","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-inflammatory effects of metformin irrespective of diabetes status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000443897","article-title":"The impact of pharmacotherapy of type 2 diabetes mellitus on IL-1\u03b2, IL-6 and IL-10 secretion","volume":"97","author":"Borowska","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejmech.2025.118065_bib103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-017-0551-5","article-title":"The addition of vildagliptin to metformin prevents the elevation of interleukin 1\u00df in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study","volume":"16","author":"Younis","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib104","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12902-022-01176-3","article-title":"Growth differentiation factor 15 is not associated with glycemic control in patients with type 2 diabetes mellitus treated with metformin: a post-hoc analysis of AIM study","volume":"22","author":"Gao","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib105","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1152\/ajpendo.00221.2019","article-title":"Combined effects of Scutellaria baicalensis with metformin on glucose tolerance of patients with type 2 diabetes via gut microbiota modulation","volume":"318","author":"Shin","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2025.118065_bib106","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.dsx.2017.11.003","article-title":"Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-na\u00efve pre-diabetic and diabetic patients: a randomized controlled study","volume":"12","author":"Bulatova","year":"2018","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.ejmech.2025.118065_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114535","article-title":"The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats","volume":"161","author":"Arag\u00f3n-Herrera","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111624","article-title":"SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction","volume":"139","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib109","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118065_bib110","article-title":"Empagliflozin suppresses urinary mitochondrial DNA copy numbers and interleukin-1\u03b2 in type 2 diabetes patients","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116135","article-title":"Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic rats: a stereological and biochemical study","volume":"223","author":"Kiani","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105158","article-title":"Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice","volume":"150","author":"Khan","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2025.118065_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113222","article-title":"SGLT2 inhibitor-empagliflozin treatment ameliorates diabetic retinopathy manifestations and exerts protective effects associated with augmenting branched chain amino acids catabolism and transportation in db\/db mice","volume":"152","author":"Gong","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118065_bib114","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00018-022-04289-z","article-title":"Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin","volume":"79","author":"La Grotta","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109506","article-title":"Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition","volume":"68","author":"Das","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.118065_bib116","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.humimm.2021.03.004","article-title":"Changes in T helper cell-related factors in patients with type 2 diabetes mellitus after empagliflozin therapy","volume":"82","author":"Borzouei","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ejmech.2025.118065_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107492","article-title":"The SGLT2 inhibitor empagliflozin negatively regulates IL-17\/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK\/mTOR\/autophagy pathway","volume":"94","author":"Meng","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib118","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/biomedicines10112983","article-title":"Molecular mechanisms linking empagliflozin to renal protection in the LLC-PK1 model of diabetic nephropathy","volume":"10","author":"Mihaljevi\u0107","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118065_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417380","article-title":"Improved glycaemic control and nephroprotective effects of empagliflozin and paricalcitol Co-Therapy in mice with type 2 diabetes mellitus","volume":"24","author":"Mujalli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib120","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2147\/DMSO.S243170","article-title":"Empagliflozin protects against proximal renal tubular cell injury induced by high glucose via regulation of hypoxia-inducible factor 1-alpha, Diabetes","volume":"13","author":"Ndibalema","year":"2020","journal-title":"Metab Syndr Obes."},{"key":"10.1016\/j.ejmech.2025.118065_bib121","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12272-022-01391-5","article-title":"Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling","volume":"45","author":"Abdelkader","year":"2022","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2025.118065_bib122","first-page":"384","article-title":"Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis","volume":"22","author":"Jigheh","year":"2019","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.ejmech.2025.118065_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108503","article-title":"Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation","volume":"104","author":"Hazem","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111785","article-title":"Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p\/HO-1\/NLRP3 axis modulation","volume":"131","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114088","article-title":"Dapagliflozin attenuates skeletal muscle atrophy in diabetic nephropathy mice through suppressing Gasdermin D-mediated pyroptosis","volume":"148","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6305735","article-title":"The SGLT-2 inhibitor Dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE-\/- mice","volume":"2016","author":"Leng","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejmech.2025.118065_bib127","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3892\/mmr.2023.13087","article-title":"Dapagliflozin alleviates renal podocyte pyroptosis via regulation of the HO-1\/NLRP3 axis","volume":"28","author":"Zhang","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108631","article-title":"Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors","volume":"38","author":"Xu","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ejmech.2025.118065_bib129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12872-024-04022-7","article-title":"Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy","volume":"24","author":"Dihoum","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ejmech.2025.118065_bib130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-024-02294-z","article-title":"Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure","volume":"23","author":"Wang","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib131","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i2.97287","article-title":"Xiao-Lei, Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase\/protein kinase B signaling pathway","volume":"16","author":"Xiong","year":"2025","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejmech.2025.118065_bib132","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/cells10061457","article-title":"Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated hk-2 cells","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118065_bib133","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2023.2266736","article-title":"Novel insights about synergistic effect of Zamzam water with SGL2 inhibitors on wound healing in STZ-induced diabetic rats: the role of anti-inflammatory and proangiogenic effects","volume":"36","author":"Taha","year":"2023","journal-title":"J Investig Surg"},{"key":"10.1016\/j.ejmech.2025.118065_bib134","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10557-020-06978-y","article-title":"Dapagliflozin and ticagrelor have additive effects on the attenuation of the activation of the NLRP3 inflammasome and the progression of diabetic cardiomyopathy: an AMPK\u2013mTOR interplay","volume":"34","author":"Chen","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejmech.2025.118065_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116795","article-title":"Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease","volume":"233","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib136","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1248\/bpb.b22-00241","article-title":"Skin dryness induced in the KK-Ay\/TaJcl type 2 diabetes mouse model deteriorates following dapagliflozin administration","volume":"45","author":"Horikawa","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2025.118065_bib137","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1038\/s41598-025-91278-4","article-title":"Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL\/6J mice","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib138","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fendo.2019.00441","article-title":"Dapagliflozin attenuates renal tubulointerstitial fibrosis associated with type 1 diabetes by regulating STAT1\/TGF\u03b21 signaling","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib139","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416107","article-title":"Dapagliflozin prevents high-glucose-induced cellular senescence in renal tubular epithelial cells","volume":"23","author":"Eleftheriadis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib140","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109617","article-title":"Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT\/JAK\/MAPK pathways in streptozotocin-induced diabetic rats","volume":"347","author":"El-Sayed","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2025.118065_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.862394","article-title":"Role of dapagliflozin and liraglutide on diabetes-induced cardiomyopathy in rats: implication of oxidative stress, inflammation, and apoptosis","volume":"13","author":"El-Shafey","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejmech.2025.118065_bib143","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/life12050764","article-title":"Dapagliflozin, liraglutide, and their combination attenuate diabetes mellitus-associated hepato-renal injury\u2014insight into oxidative injury\/inflammation\/apoptosis modulation","volume":"12","author":"El-Sherbiny","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2025.118065_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119018","article-title":"Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; inflammation, angiogenesis and apoptosis","volume":"280","author":"Elkazzaz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12933-023-02027-8","article-title":"Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial","volume":"22","author":"Koshino","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib146","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13287-025-04130-x","article-title":"Cardio-renal effect of dapagliflozin and dapagliflozin- saxagliptin combination on CD34 + ve hematopoietic stem cells (HSCs) and podocyte specific markers in type 2 diabetes (T2DM) subjects: a randomized trial","volume":"16","author":"Nandula","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejmech.2025.118065_bib147","article-title":"GLP-1 alleviates NLRP3 inflammasome-dependent inflammation in perivascular adipose tissue by inhibiting the NF-\u03baB signalling pathway","volume":"49","author":"Chen","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1136070","article-title":"Effects of liraglutide on astrocyte polarization and neuroinflammation in db\/db mice: focus on iron overload and oxidative stress","volume":"17","author":"An","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118065_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100813","article-title":"Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes","volume":"3","author":"Gutierrez","year":"2022","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib150","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.numecd.2021.07.015","article-title":"Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus","volume":"31","author":"Guarnotta","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ejmech.2025.118065_bib151","doi-asserted-by":"crossref","first-page":"157","DOI":"10.17219\/acem\/130605","article-title":"Liver paraoxonase 3 expression and the effect of liraglutide treatment in a rat model of diabetes","volume":"30","author":"Liu","year":"2021","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib152","first-page":"4818","article-title":"Liraglutide improves pancreatic islet \u03b2 cell apoptosis in rats with type 2 diabetes mellitus by inhibiting the IKK\u03b5\/NF-\u03baB pathway","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib153","first-page":"2977","article-title":"GLP-1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK\/NF-\u03baB signaling pathways in streptozotocin-induced diabetic rats","volume":"41","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.118065_bib154","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8974960","article-title":"Liraglutide attenuates hepatic oxidative stress, inflammation, and apoptosis in streptozotocin-induced diabetic mice by modulating the Wnt\/\u03b2-Catenin signaling pathway","volume":"2023","author":"Yu","year":"2023","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejmech.2025.118065_bib155","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13577-024-01038-1","article-title":"Liraglutide prevents cellular senescence in human retinal endothelial cells (HRECs) mediated by SIRT1: an implication in diabetes retinopathy","volume":"37","author":"Hou","year":"2024","journal-title":"Hum. Cell"},{"key":"10.1016\/j.ejmech.2025.118065_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119374","article-title":"Combined therapy of mesenchymal stem cells with a GLP-1 receptor agonist , liraglutide , on an inflammatory-mediated diabetic non-human primate model","volume":"276","author":"Navabi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2020.101382","article-title":"Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4\/NF-kB inflammatory pathway and oxidative stress in T2DM\/NAFLD rats","volume":"66","author":"Xu","year":"2020","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ejmech.2025.118065_bib158","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fphar.2020.00372","article-title":"A GLP-1 analog liraglutide reduces intimal hyperplasia after coronary stent implantation via regulation of glycemic variability and NLRP3 Inflammasome\/IL-10 signaling in diabetic swine","volume":"11","author":"Xia","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib159","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jnc.14336","article-title":"Liraglutide ameliorated peripheral neuropathy in diabetic rats: involvement of oxidative stress, inflammation and extracellular matrix remodeling","volume":"146","author":"Moustafa","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.118065_bib160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2119\/molmed.2016.00168","article-title":"Liraglutide enhances the efficacy of human mesenchymal stem cells in preserving islet \u03b2-cell function in severe Non-obese diabetic mice","volume":"22","author":"Li","year":"2016","journal-title":"Mol Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib161","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/09546634.2019.1708853","article-title":"Liraglutide improved inflammation via mediating IL-23\/Th-17 pathway in obese diabetic mice with psoriasiform skin","volume":"32","author":"Chen","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ejmech.2025.118065_bib162","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/09546634.2020.1826392","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide therapy for psoriasis patients with type 2 diabetes: a randomized-controlled trial","volume":"33","author":"Lin","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ejmech.2025.118065_bib163","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bjd.12886","article-title":"Improvement of psoriasis during glucagon-like peptide-1 analogue therapy in type 2 diabetes is associated with decreasing dermal \u03b3\u03b4 T-cell number: a prospective case-series study","volume":"171","author":"Buysschaert","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2025.118065_bib164","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2017.09.006","article-title":"Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model","volume":"137","author":"Chen","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2025.118065_bib165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-024-05558-9","article-title":"The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy","volume":"82","author":"Kuo","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib166","first-page":"22","article-title":"Liraglutide attenuates restenosis after vascular injury in rabbits with diabetes via the TGF-\u03b2\/Smad3 signaling pathway","volume":"28","author":"Ding","year":"2022","journal-title":"Altern Ther Health Med"},{"key":"10.1016\/j.ejmech.2025.118065_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1224985","article-title":"Liraglutide ameliorates diabetic-induced testicular dysfunction in male rats: role of GLP-1\/Kiss1\/GnRH and TGF-\u03b2\/Smad signaling pathways","volume":"14","author":"Fathy","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib168","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8873956","article-title":"Liraglutide regulates the kidney and liver in diabetic nephropathy rats through the miR-34a\/SIRT1 pathway","author":"Xiao","year":"2021","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejmech.2025.118065_bib169","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.2147\/DDDT.S224688","article-title":"Liraglutide improves non-alcoholic fatty liver disease in diabetic mice by modulating inflammatory signaling pathways","volume":"13","author":"Luo","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejmech.2025.118065_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38932","article-title":"New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival via suppression of TXNIP\/NLRP3 pyroptosis signaling in streptozocin\u2013induced diabetes mellitestype-1 in rats","volume":"10","author":"Khalifa","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2025.118065_bib171","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12020-024-03998-8","article-title":"Comparison of the effects of liraglutide, tirzepatide, and retatrutide on diabetic kidney disease in db\/db mice","author":"Ma","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.ejmech.2025.118065_bib172","article-title":"PLGA\/HA sustained-release system loaded with liraglutide for the treatment of diabetic periodontitis through inhibition of necroptosis","volume":"31","author":"Pang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejmech.2025.118065_bib173","doi-asserted-by":"crossref","first-page":"218","DOI":"10.29271\/jcpsp.2019.03.218","article-title":"Effects of liraglutide combined with insulin on oxidative stress and serum MCP-1 and NF-B levels in type 2 diabetes","volume":"29","author":"Liu","year":"2019","journal-title":"J Coll Physicians Surg Pakistan"},{"key":"10.1016\/j.ejmech.2025.118065_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113140","article-title":"Combined effect of SDF-1 peptide and angiogenic cues in co-axial PLGA\/gelatin fibers for cutaneous wound healing in diabetic rats","volume":"223","author":"Shafiq","year":"2023","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.ejmech.2025.118065_bib175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12933-022-01486-9","article-title":"Liraglutide preserves CD34+ stem cells from dysfunction induced by high glucose exposure","volume":"21","author":"Sforza","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib176","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97967-0","article-title":"Effect of liraglutide on expression of inflammatory genes in type 2 diabetes","volume":"11","author":"Zobel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118065_bib177","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/dom.14903","article-title":"Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: a randomized controlled trial","volume":"25","author":"Mashayekhi","year":"2023","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.ejmech.2025.118065_bib178","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/bcp.14063","article-title":"Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy","volume":"85","author":"Brock","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118065_bib179","first-page":"1141","article-title":"Assessment of complex treatment influence on systemic inflammation in overweight type 2 diabetes patients","volume":"71","author":"V Said","year":"2020","journal-title":"Wiadomo\u015bci Lek"},{"key":"10.1016\/j.ejmech.2025.118065_bib180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/dom.12884","article-title":"Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: a sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial","volume":"19","author":"von Scholten","year":"2017","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.ejmech.2025.118065_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166770","article-title":"Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice","volume":"1869","author":"Iwai","year":"2023","journal-title":"Biochim Biophys Acta - Mol Basis Dis."},{"key":"10.1016\/j.ejmech.2025.118065_bib182","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/ijms25031854","article-title":"Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process","volume":"25","author":"Hachu\u0142a","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118065_bib183","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/biomedicines9080926","article-title":"Effects of the topical administration of semaglutide on retinal neuroinflammation and vascular leakage in experimental diabetes","volume":"9","author":"Sim\u00f3","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118065_bib184","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cells13221857","article-title":"Semaglutide ameliorates diabetic neuropathic pain by inhibiting neuroinflammation in the spinal cord","volume":"13","author":"Lee","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118065_bib185","article-title":"Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study","author":"Petralli","year":"2025","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejmech.2025.118065_bib186","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5414\/CP203787","article-title":"Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: a single-arm real-world observation","volume":"59","author":"Singh","year":"2021","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ejmech.2025.118065_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108610","article-title":"Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease","volume":"37","author":"Shi","year":"2023","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ejmech.2025.118065_bib188","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/dc18-1569","article-title":"The SGLT2 inhibitor dapagliflozin reduces liver fat but does not affect tissue insulin sensitivity: a randomized, double-blind, placebo-controlled study with 8-week treatment in type 2 diabetes patients","volume":"42","author":"Latva-Rasku","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2025.118065_bib189","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/biom15010046","article-title":"Effects of semaglutide treatment on psoriatic lesions in Obese patients with type 2 diabetes mellitus: an open-label, randomized clinical trial","volume":"15","author":"Petkovi\u0107-Dabi\u0107","year":"2025","journal-title":"Biomolecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500830X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342500830X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:01:12Z","timestamp":1772802072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342500830X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":189,"alternative-id":["S022352342500830X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118065","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory effects of anti-diabetic therapies: Cytokine and chemokine modulation by metformin, sodium-glucose cotransporter 2 inhibitors, and glucagon-like peptide-1 receptor agonists (2013\u20132025)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118065"}}